Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein- Barr virus oncogene LMP1

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7819-7826

  Franken, Michael ^a   Devergne, Odile ^a,b   Rosenzweig, Michael ^b   Annis, Bethany ^a   Kieff, Elliott ^a,b   Wang, Fred ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BABOON; CONTROLLED STUDY; EMBRYO; EPSTEIN BARR VIRUS; GENETIC CONSERVATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RHESUS MONKEY; SIGNAL TRANSDUCTION; VIRUS CARCINOGENESIS; VIRUS ENVELOPE; VIRUS ONCOGENE;

EID: 0029821260     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7819-7826.1996     Document Type: Article

References (52)

1. Ablashi, D. V., P. Gerber, and J. Easton. 1979. Oncogenic herpesviruses of nonhuman primates. Comp. Immunol. Microhiol. Infect. Dis. 2:229-241.
2. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J. P. Galizzi, C. van Kooten, Y. J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
3. Birkenbach, M., D. Liebowitz, F. Wang, J. Sample, and E. Kieff. 1989. Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines. J. Virol. 63:4079-4084.
4. Cheng, G., A. M. Cleary, Z. S. Ye, D. I. Hong, S. Lederman, and D. Baltimore. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267:1494-1498.
5. Devergne, O., G. Mosialos, and E. Kieff. Unpublished data.
6. Dunkel, V. C., T. W. Pry, G. Henle, and W. Henle. 1972. Immunofluorescence tests for antibodies to Epstcin-Barr virus with sera of lower primates. J. Natl. Cancer Inst. 49:435-440.
7. Falini, B., S. Pileri, G. Pizzolo, H. Durkop, L. Flenghi, F. Stirpe, M. F. Martelli, and H. Stein. 1995. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85:1-14.
8. Falk, L., F. Deinhardt, M. Nonoyama, L. G. Wolfe, and C. Bergholz. 1976. Properties of a baboon lymphotropic herpesvirus related to Epstein-Barr virus. Int. J. Cancer 18:798-807.
9. Feichtinger, H., P. Putkonen, C. Parravicini, S. T. Li, E. E. Kaya, D. Bottiger, and P. Biberfeld. 1990. Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus. Am. J. Pathol. 137:1311-1315.
10. Frank, A., W. A. Andiman, and G. Miller. 1976. Epstein-Barr virus and nonhuman primates: natural and experimental infection. Adv. Cancer Res. 23:171-201.
11. Franken, M. Unpublished data.
12. Franken, M., B. Annis, A. Ali, and F. Wang. 1995. 5′ coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio. J. Virol. 69:8011-8019.
13. Gerber, P., S. S. Kalter, G. Schidlovsky, W. J. Peterson, and M. D. Daniel. 1977. Biologic and antigenic characteristics of Epstein-Barr virus-related herpesviruses of chimpanzees and baboons. Int. J. Cancer 20:448-459.
14. Hammarskjold, M. L., and M. C. Simurda. 1992. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity. J. Virol. 66:6496-6501.
15. Hammerschmidt, W., B. Sugden, and V. R. Baichwal. 1989. The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J. Virol. 63:2469-2475.
16. Heller, M., P. Gerber, and E. Kieff. 1981. Herpesvirus papio DNA is similar in organization to Epstein-Barr virus DNA. J. Virol. 37:698-709.
17. Henderson, S., M. Rowe, C. Gregory, D. Croom-Carter, F. Wang, R. Longnecker, E. Kieff, and A. Rickinson. 1991. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115.
18. Herbst, H., F. Dallenbach, M. Hummel, G. Niedobitek, S. Pileri, N. Muller-Lantzsch, and H. Stein. 1991. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc. Natl. Acad. Sci. USA 88:4766-4770.
19. Hu, H. M., K. O'Rourke, M. S. Boguski, and V. M. Dixit. 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269:30069-30072.
20. Huen, D. S., S. A. Henderson, D. Croom-Carter, and M. Rowe. 1995. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10:549-560.
21. Inui, S., T. Kaisho, H. Kikutani, I. Stamenkovic, B. Seed, E. A. Clark, and T. Kishimoto. 1990. Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40. Eur. J. Immunol. 20:1747-1753.
22. Irving, B. A., and A. Weiss. 1991. The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways. Cell 64:891-901.
23. Kalter, S. S., R. L. Heberling, and J. J. Ratner. 1972. EBV antibody in sera of nonhuman primates. Nature (London) 238:353-354.
24. Kaye, K. M., K. M. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90:9150-9154.
25. Kaye, K. M., K. M. Izumi, G. Mosialos, and E. Kieff. 1995. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation: fibroblast cocultivation complements a critical function within the terminal 155 residues. J. Virol. 69:675-683.
26. Laherty, C. D., H. M. Hu, A. W. Opipari, F. Wang, and V. M. Dixit. 1992. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J. Biol. Chem. 267:24157-24160.
27. Landon, J. C., L. B. Ellis, V. H. Zeve, and D. P. Fabrizio. 1968. Herpes-type virus in cultured leukocytes from chimpanzees. J. Natl. Cancer Inst. 40:181-192.
28. Lapin, B. A. 1974. The epidemiologic and genetic aspect of an outbreak of leukemia among baboons of the Sukhumi monkey colony in Dutcher and Chieco-Bianchi. Unifying concepts of leukemia. Bibl. Haematol. 39:263-268.
29. Lee, S. P., W. A. Thomas, R. J. Murray, F. Khanim, S. Kaur, L. S. Young, M. Rowe, M. Kurilla, and A. B. Rickinson. 1993. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J. Virol. 67:7428-7435.
30. Liebowtz, D., J. Mannick, K. Takada, and E. Kieff. 1992. Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells. J. Viral. 66:4612-4616.
31. Ling, P. D., and S. D. Hayward. 1995. Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk. J. Virol. 69:1944-1950.
32. Ling, P. D., J. J. Ryon, and S. D. Hayward. 1993. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved Hydrophobic motif. J. Virol. 67:2990-3003.
33. Martin, J. M., D. Veis, S. J. Korsmeyer, and B. Sugden. 1993. Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. J. Virol. 67:5269-5278.
34. Miller, W. E., R. H. Edwards, D. M. Walling, and N. Raab-Traub. 1994. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J. Gen. Virol. 75:2729-2740.
35. Mitchell, T., and B. Sugden. 1995. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69:2968-2976.
36. Moghaddam, A., and F. Wang. Unpublished observations.
37. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399.
38. Myers, C. L., S. J. Wertheimer, J. Schembri-King, T. Parks, and R. W. Wallace. 1992. Induction of ICAM-1 by TNF-alpha, IL-1 beta, and LPS in human endothelial cells after downregulation of PKC. Am. J. Physiol. 263: C767-C772.
39. Pathmanathan, R., U. Prasad, R. Sadler, K. Flynn, and N. Raab-Traub. 1995. Clonal proliferations of cells infected with Epstein-Barr virus in pre-invasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med. 333: 693-698.
40. Peng, M., and E. Lundgren. 1992. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Oncogene 7:1775-1782.
41. Rabin, H., R. H. Neubauer, R. F. D. Hopkins, and M. Nonoyama. 1978. Further characterization of a herpesvirus-positive orang-utan cell line and comparative aspects of in vitro transformation with lymphotropic old world primate herpesviruses. Int. J. Cancer 21:762-767.
42. Rangan, S. R., L. N. Martin, B. E. Bozelka, N. Wang, and B. J. Gormus. 1986. Epstein-Barr virus-related herpesvirus from a rhesus monkey (Macaca mulatta) with malignant lymphoma. Int. J. Cancer 38:425-432.
43. Rickinson, A, and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In D. Knipe, B. Fields, and P. Howley (ed.). Fields virology. Raven Press, Philadelphia.
44. Rowe, M., M. Peng-Pilon, D. S. Huen, R. Hardy, D. Croom-Carter, E. Lundgren, and A. B. Rickinson. 1994. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers. J. Virol. 68:5602-5612.
45. Sample, J., E. F. Kieff, and E. D. Kieff. 1994. Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes. J. Gen. Virol. 75:2741-2746.
46. Wang, D., D. Liebowitz, and E. Kieff. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
47. Wang, F., C. Gregory, C. Sample, M. Rowe, D. Liebowitz, R. Murray, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309-2318.
48. Wang, F., S. F. Tsang, M. G. Kurilla, J. I. Cohen, and E. Kieff. 1990. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J. Virol. 64:3407-3416.
49. Wertheimer, S. J., C. L. Myers, R. W. Wallace, and T. P. Parks. 1992. Intercellular adhesion molecule-1 gene expression in human endothelial cells. Differential regulation by tumor necrosis factor-alpha and phorbol myristate acetate. J. Biol. Chem. 267:12030-12035.
50. Yao, Q. Y, P. Ogan, M. Rowe, M. Wood, and A. B. Rickinson. 1989. Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers. Int. J. Cancer 43:67-71.
51. Young, L., C. Alfieri, K. Hennessy, H. Evans, C. O'Hara, K. C. Andersen, J. Ritz, R. S. Shapiru, A. Rickinson, E. Kieff, et al. 1989. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321:1080-1085.
52. Zhang, Q., L. Brooks, P. Busson, F. Wang, D. Charron, E. Kieff, A. B. Rickinson, and T. Tursz. 1994. Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line. Eur. J. Immunol. 24:1467-1470.